As more patients take GLP-1 medications, it’s common for patient questions to arise about how alcohol consumption may affect ...

GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t ...

Add Yahoo as a preferred source to see more of our stories on Google. The World Health Organization has laid down its first guidelines for GLP-1 drugs like Wegovy and Zepbound. 'We know that consumers ...

Discover why poultry demand remains resilient despite GLP-1 weight-loss drugs and dietary shifts. New data reveals the real impact on meat consumption patterns.

WashU Medicine researchers find in a new study that GLP-1 use is tied to reductions in substance use disorders and serious outcomes across all types of addictive substances.

According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...

Results showed that use of GLP-1 receptor agonists did not increase short-term medical or surgical complications among ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care A new study finds that people who quit weight-loss medications ...

A study by WashU Medicine researchers finds GLP-1 use is associated with seven fewer new cases of substance use disorder and 12 fewer harmful events related to substance use among every 1,000 people ...

A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing ...

GLP-1 drugs protect against new or worsening addictions, large study shows – Nation and World News | West Hawaii Today ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...